A detailed history of Sea Crest Wealth Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Sea Crest Wealth Management, LLC holds 17,463 shares of NVO stock, worth $1.89 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
17,463
Previous 17,536 0.42%
Holding current value
$1.89 Million
Previous $2.5 Million 16.94%
% of portfolio
0.23%
Previous 0.29%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$119.07 - $145.42 $8,692 - $10,615
-73 Reduced 0.42%
17,463 $2.08 Million
Q2 2024

Jul 19, 2024

BUY
$122.71 - $146.91 $58,287 - $69,782
475 Added 2.78%
17,536 $2.5 Million
Q1 2024

Apr 18, 2024

SELL
$102.11 - $135.92 $10,823 - $14,407
-106 Reduced 0.62%
17,061 $2.19 Million
Q4 2023

Jan 18, 2024

BUY
$87.78 - $105.45 $270,625 - $325,102
3,083 Added 21.89%
17,167 $1.78 Million
Q3 2023

Oct 12, 2023

BUY
$90.94 - $199.54 $778,264 - $1.71 Million
8,558 Added 154.87%
14,084 $1.28 Million
Q2 2023

Jul 14, 2023

BUY
$155.98 - $172.65 $115,581 - $127,933
741 Added 15.49%
5,526 $894,000
Q1 2023

May 11, 2023

BUY
$132.34 - $159.14 $136,177 - $163,755
1,029 Added 27.4%
4,785 $761,000
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $79,168 - $104,474
772 Added 25.87%
3,756 $508,000
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $31,061 - $38,119
326 Added 12.26%
2,984 $297,000
Q2 2022

Aug 09, 2022

SELL
$103.24 - $121.81 $1,548 - $1,827
-15 Reduced 0.56%
2,658 $296,000
Q1 2022

May 16, 2022

BUY
$93.1 - $112.54 $43,757 - $52,893
470 Added 21.33%
2,673 $297,000
Q4 2021

Feb 11, 2022

SELL
$95.88 - $117.08 $3,164 - $3,863
-33 Reduced 1.48%
2,203 $247,000
Q3 2021

Nov 16, 2021

SELL
$84.42 - $106.62 $12,831 - $16,206
-152 Reduced 6.37%
2,236 $215,000
Q2 2021

Aug 12, 2021

BUY
$67.66 - $84.76 $161,572 - $202,406
2,388 New
2,388 $200,000
Q1 2020

May 13, 2020

SELL
$49.46 - $64.78 $173,011 - $226,600
-3,498 Closed
0 $0
Q4 2019

Jan 22, 2020

BUY
$49.86 - $58.26 $174,410 - $203,793
3,498 New
3,498 $202,000
Q2 2019

Jul 19, 2019

SELL
$46.79 - $52.47 $186,130 - $208,725
-3,978 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$46.36 - $52.63 $5,331 - $6,052
115 Added 2.98%
3,978 $208,000
Q4 2018

Feb 13, 2019

SELL
$41.54 - $47.25 $2,866 - $3,260
-69 Reduced 1.75%
3,863 $178,000
Q3 2018

Nov 14, 2018

BUY
$46.76 - $51.24 $23,520 - $25,773
503 Added 14.67%
3,932 $185,000
Q2 2018

Aug 03, 2018

BUY
$44.29 - $50.42 $1,372 - $1,563
31 Added 0.91%
3,429 $158,000
Q1 2018

Apr 20, 2018

BUY
$48.49 - $58.14 $5,333 - $6,395
110 Added 3.35%
3,398 $167,000
Q4 2017

Feb 02, 2018

BUY
$47.53 - $53.73 $156,278 - $176,664
3,288
3,288 $176,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Sea Crest Wealth Management, LLC Portfolio

Follow Sea Crest Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.